3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Vaping
1
Uterine Cervical Dysplasia
1
Smoking Cessation
1
Pain
1
Nevus, Spindle Cell
1
Nevus, Pigmented
1
Nevus, Epithelioid and Spindle Cell
1
Nevus, Blue
1
Nevus
1
Neoplasms
1
Mycosis Fungoides
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Dysplastic Nevus Syndrome
1
Cutaneous Squamous Cell Carcinoma
1
Breast Neoplasms
1
Agnosia
1
Interventions
Peripheral Blood Stem Cell Transplantation
38
fludarabine phosphate
37
Cyclophosphamide
33
Mycophenolic Acid
28
Whole-Body Irradiation
24
Cyclosporine
24
Tacrolimus
22
Radiotherapy
19
Methotrexate
18
Busulfan
18
Antilymphocyte Serum
17
Filgrastim
14
Etoposide
14
Vorinostat
11
Bortezomib
11
Bexarotene
11
Methylprednisolone
10
Lenalidomide
10
pembrolizumab
9
Rituximab
9
Melphalan
9
Gemcitabine
9
Flow Cytometry
9
Brentuximab Vedotin
9
romidepsin
8
mogamulizumab
8
Methoxsalen
8
fludarabine
7
Magnetic Resonance Spectroscopy
7
Cord Blood Stem Cell Transplantation
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Mycosis Fungoides
×
Transdermal Patch
×
Clear all
NCT02192021
2024-08-09
MNA-D
University of Pittsburgh
Phase 1
Completed
20 enrolled